Carmot Therapeutics Closes $160 Million Series D Financing to Advance Clinical Pipeline of Novel Incretin Receptor Modulators Portfolio News / By Karina Tin July 26, 2022
Kallyope and Brightseed Enter Collaboration to Identify and Validate Novel Plant-Based Bioactives Portfolio News / By Karina Tin July 21, 2022
Nurix Therapeutics Announces $40 Million Registered Direct Offering Portfolio News / By Karina Tin July 8, 2022
Nurix Therapeutics Announces $55 Million Registered Direct Offering Portfolio News / By Karina Tin July 7, 2022
Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update Portfolio News / By Karina Tin July 7, 2022
Kallyope, Pioneers in Drug Discovery via the Gut-Brain Axis, Advances Discovery and Development Teams With New Appointments Portfolio News / By Karina Tin July 6, 2022
Tenaya Therapeutics Publishes Preclinical Data in Science Translational Medicine Detailing Discovery of HDAC6 Inhibitor for Treatment of Heart Failure Portfolio News / By Karina Tin July 6, 2022
